Literature DB >> 25920313

Insulin resistance in pregnancy complicated by type 1 diabetes mellitus. Do we know enough?

Paweł Gutaj, Nadia Sawicka-Gutaj, Maciej Brazert, Ewa Wender-Ozegowska.   

Abstract

Insulin resistance (IR) is defined clinically as the inability of a known quantity of exogenous or endogenous insulin to increase glucose uptake and utilization. In recent years the increasing role of IR in the pathogenesis of type 1 diabetes mellitus (T1DM) related complications has been taken into account. The aim of this article is to discuss the possible role of IR in pregnancy complicated by T1DM. At the moment, there is no doubt that IR is not only frequently observed in T1DM patients, but also is a separate risk factor of several complications in nonpregnant patients. The role of IR in pregnancy complicated by T1DM has not been widely studied yet. However, data from the studies on different populations showed that IR may predispose to such conditions as miscarriage, preeclampsia and macrosomia. Interestingly all of these are more frequently diagnosed in women with T1DM in comparison to healthy subjects. The literature on the role of IR in human pregnancy is relatively rich. However despite its significance in pathophysiology of T1DM and its complications in general population, there is a lack of understanding of how it affects maternal and fetal health in pregnancy complicated by this disease. Nonetheless, based on the available literature, IR may be proposed as an additional factor modifying pregnancy outcome in woman with T1DM. Therefore, measures that might reduce IR such as good glycemic control and control of weight gain should be recommended for every woman with T1DM, optimally when planning but also throughout the pregnancy

Entities:  

Mesh:

Year:  2015        PMID: 25920313     DOI: 10.17772/gp/2065

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  5 in total

1.  Maternal serum proteomic profiles of pregnant women with type 1 diabetes.

Authors:  Marzena Gajecka; Ewa Wender-Ozegowska; Paweł Gutaj; Jan Matysiak; Eliza Matuszewska; Katarzyna Jaskiewicz; Dorota Kamińska; Agata Światły-Błaszkiewicz; Tomasz Szczapa; Anastasia Kalantarova
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

2.  Pre-Eclampsia Biomarkers for Women With Type 1 Diabetes Mellitus: A Comprehensive Review of Recent Literature.

Authors:  Katrina Z Freimane; Lauren Kerrigan; Kelly-Ann Eastwood; Chris J Watson
Journal:  Front Bioeng Biotechnol       Date:  2022-05-26

Review 3.  Diagnosis and Management of IUGR in Pregnancy Complicated by Type 1 Diabetes Mellitus.

Authors:  Paweł Gutaj; Ewa Wender-Ozegowska
Journal:  Curr Diab Rep       Date:  2016-05       Impact factor: 4.810

Review 4.  Obstetric and offspring risks of women's morbid conditions linked to prior anticancer treatments.

Authors:  Juan J Tarín; Miguel A García-Pérez; Antonio Cano
Journal:  Reprod Biol Endocrinol       Date:  2016-07-07       Impact factor: 5.211

5.  Determinants of preeclampsia in women with type 1 diabetes.

Authors:  Paweł Gutaj; Agnieszka Zawiejska; Urszula Mantaj; Ewa Wender-Ożegowska
Journal:  Acta Diabetol       Date:  2017-10-03       Impact factor: 4.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.